Thursday, August 17, 2017 8:46:59 AM
Matthew Geriak, PharmD - Clinical Pharmacist- Investigational Research Pharmacist. Dr. Geriak is a specialized Pharmacist and has a
system-wide position on the Investigational Review Board for Sharp Healthcare. Sharp has 5 hospitals and various clinics throughout
San Diego County. His Drug Research spans from Phase 1 to 4 Human Research Clinical Trials with the focus in the fields of Oncology,
Renal and Heart Transplantations, Septic Shock treatment, Infectious Diseases and Anticoagulation. Mr. Geriak is the primary Investigator
for retrospective cohorts in the field of Infectious Diseases. He also has held positions as a Clinical Pharmacist in the Acute Care
department at Scripps Mercy Hospital in San Diego, and was an infectious Disease Specialist with Sharp HealthCare in San Diego. His
responsibilities were to bring the Antibiotic Stewardship to the next level by developing/mentoring a Pharmacy Residency Infectious
Disease Rotation, round with the ID physicians, create antibiotic utilization guidelines for surgical prophylaxis, and provide entity input
to the system-wide Antimicrobial Review Committee. Education: University of Southern California.
Jessie Kempf - Real Estate Attorney. Mrs. Kempf frequently draws on her experience as a real estate attorney, while helping cannabis
cultivators and distributors grow their businesses. After obtaining a B.A. in Music, a B.A. in History, and a J.D. from UT Austin, Jessie
began her career with Skadden, Arps in Manhattan, where she assisted institutional banks and Fortune 500 companies with highprofile
mergers, financings, and IPOs. She currently works for a real estate boutique in Orange County, helping developers to finance,
acquire, and entitle commercial properties.
In addition to being a member of the California and New York bars, Jessie is actively involved in “Women Grow” and is passionate
about the use of cannabis for medicinal purposes. She’s excited to be working with a team of like-minded individuals at LiveWire,
who are committed to developing technologies and strategies that will shape the future of medical cannabis.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM